Verity Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-4,572
| Closed | -$326K | – | 145 |
|
|
2019
Q2 | $326K | Buy |
4,572
+770
| +20% | +$54.9K | 0.37% | 87 |
|
|
2019
Q1 | $298K | Buy |
3,802
+197
| +5% | +$15.4K | 0.34% | 86 |
|
|
2018
Q4 | $305K | Buy |
3,605
+822
| +30% | +$69.5K | 0.41% | 68 |
|
|
2018
Q3 | $477K | Sell |
2,783
-478
| -15% | -$81.9K | 0.47% | 47 |
|
|
2018
Q2 | $421K | Sell |
3,261
-1,126
| -26% | -$145K | 0.38% | 48 |
|
|
2018
Q1 | $452K | Buy |
4,387
+216
| +5% | +$22.3K | 0.41% | 45 |
|
|
2017
Q4 | $410K | Sell |
4,171
-3
| -0.1% | -$295 | 0.31% | 54 |
|
|
2017
Q3 | $378K | Sell |
4,174
-460
| -10% | -$41.7K | 0.29% | 53 |
|
|
2017
Q2 | $351K | Buy |
4,634
+862
| +23% | +$65.3K | 0.26% | 63 |
|
|
2017
Q1 | $249K | Buy |
+3,772
| New | +$249K | 0.21% | 87 |
|